Monitoring Cancer Immune Cell Therapies
Single cell and spatial analyses of cell-based cancer therapeutics and patient responses enhance treatment efficacy.
Cell-based cancer therapies, such as chimeric antigen receptor (CAR) T cell therapy, show promise in the clinic, especially against blood-based tumors. However, researchers continue to enhance treatment efficacy in blood and solid tumors and to tailor therapeutics to patients with unique needs. A range of single cell and spatial technologies helps scientists discover new drug targets, characterize cell-based infusions, monitor therapy response in patients over time, and identify factors contributing to treatment resistance.
Download this brochure from 10x Genomics to learn how to use high-throughput single cell gene expression, single cell immune profiling, and multiomic and spatial analyses to study and optimize cell-based cancer therapeutics.
